Most of the new products introduced in the second half of this year were the more standard formats, with oils and topicals (the largest categories) seeing the newest products introduced. In addition, the German market has also seen a large number of new cannabinoid products, such as those with CBG or CBN, enter the market this year. This report offers a thorough overview of the current status of the German market, covering products, pricing and brands.
If you purchase a report that is updated in the next 60 days, we will send you the new report for free.
Reasons to buyIf you are interested in the German market and how things have changed this year, then this is the report for you. You’ll gain invaluable data and analysis of the market in terms of brands and their categories, the changes in products offered, price reductions and information relating to new cannabinoids that have started to enter the market this year.
Table of contents*This report doesn’t offer marketing lists
MethodologyUsing in-house data on the most widespread brands in both the online and offline markets, 47 unique brands were identified as being the most representative in the German market. Together, they form the sample used to analyse the offerings and pricing of CBD products throughout Germany. Where available from brand sources, product offerings were collected along with their RRPs. Where data was not available from brand sources, data from e-commerce websites was collected.
Latest reportsMost of the new products introduced in the second half of this year were the more standard formats, with oils and topicals (the largest categories) seeing the newest products introduced. In addition, the German market has also seen a large number of new cannabinoid products, such as those with CBG or CBN, enter the market this year. This report offers a thorough overview of the current status of the German market, covering products, pricing and brands.
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the CBD-Intel team.